All comparisons

Educational Wellness Information Only

This platform provides peer-reviewed research summaries and educational content about peptides for wellness and optimization purposes. Nothing on this site is intended as medical advice, diagnosis, or treatment. We do not claim any peptide can diagnose, treat, cure, or prevent any disease. Always consult a licensed healthcare provider before beginning any wellness protocol.

Statements on this site have not been evaluated by the FDA. Compounded preparations are subject to applicable state and federal regulations. Availability and eligibility vary.

Immune comparison

Thymalin vs Thymogen

An educational, source-based comparison of Thymalin and Thymogen — how each peptide works, what it's researched for, and what to know before going deeper.

Immune · Bioregulator
Thymalin

Thymic peptide complex researched for immune restoration in aging.

Mechanism

A polypeptide complex extracted from calf thymus, studied as an immune bioregulator. Research suggests restoration of T-cell function and thymic activity in aged and immunocompromised cohorts.

Research areas
  • Immunosenescence
  • Recovery from infection in elderly cohorts
  • Adjunct in chronic inflammatory conditions
Considerations
  • Approved in Russia; not FDA-approved.
  • Mixture composition is not fully characterized.
Full Thymalin profile →
Immune · Bioregulator
Thymogen

Dipeptide bioregulator for immune system modulation.

Mechanism

A synthetic dipeptide (Glu-Trp) in the Khavinson bioregulator family. Research suggests modulation of thymic and immune cell gene expression, supporting T-cell maturation and innate immune response in aged models.

Research areas
  • Immunosenescence and age-related immune decline
  • Post-infectious immune recovery
  • Chronic fatigue and immune dysregulation
Considerations
  • Russian bioregulator research; limited independent replication.
  • Not FDA-approved.
Full Thymogen profile →

Trial-evidence rating

Educational grade reflecting how many peer-reviewed studies and FDA actions we cite for each peptide. Not a clinical recommendation.

Thymalin
Preliminary

Early-stage research; conclusions are tentative.

1 cited study
Thymogen
Preliminary

Early-stage research; conclusions are tentative.

1 cited study

Study-by-study comparison

PeptideStudySourceYearSummary
ThymalinThymalin in geriatric patients: long-term outcomesAdvances in Gerontology2014Multi-year follow-up reported reduced morbidity and improved immune markers.
ThymogenThymogen and immune restoration in elderlyAdvances in Gerontology2016Improved T-cell counts and immune response markers in aged cohorts.

Side-effect & safety grid

Thymalin
  • Approved in Russia; not FDA-approved.
  • Mixture composition is not fully characterized.
Thymogen
  • Russian bioregulator research; limited independent replication.
  • Not FDA-approved.

Educational summary of considerations reported in research literature — not a complete list of adverse events. Discuss with a licensed clinician before any use.

Thymalin vs Thymogen — Key differences

  • Class: Thymalin is classified as Immune · Bioregulator, while Thymogen is Immune · Bioregulator.
  • Primary research focus: Thymalinimmunosenescence; Thymogenimmunosenescence and age-related immune decline.
  • Tag: Immune · Longevity vs Immune · Bioregulator.

Related comparisons